Ozempic could curb progression of diabetes-linked liver disease

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup